Business Context and Reporting Period
Company: Greenwave Technology Solutions, Inc.
Filing Type: Form 8-K (Current Report)
Date: March 18, 2024
Context: The Company, an emerging growth company incorporated in Delaware, reported the entry into a material definitive agreement involving a warrant exercise inducement offer and the waiver of certain debt covenants.
Key Financial Metrics and Capital Structure
This filing does not report standard operating financial metrics such as revenue, profit, cash flow, or margins. The primary financial data relates to capital structure and potential proceeds:
- Potential Gross Proceeds: Approximately $3,294,161 if all existing warrants are exercised for cash.
- Existing Warrants: Covers up to 16,147,852 shares at an exercise price of $0.204 per share.
- Inducement Warrants: New warrants to be issued for up to 32,295,704 shares (2:1 ratio) upon exercise of existing warrants.
- Debt Instrument: Senior Secured Convertible Notes issued on July 31, 2023.
Material Changes and Agreements
The filing details two significant material changes effective March 18, 2024:
- Warrant Exchange Offer:
- Holders of Existing Warrants may exercise them for cash at $0.204/share in exchange for new Inducement Warrants.
- Deadline: March 26, 2024, at 5:00 p.m. Eastern Time.
- Terms: Inducement Warrants have a 5-year term from the date of stockholder approval and include anti-dilution protections and reset provisions for reverse stock splits.
- Registration: The Company agreed to file a Form S-3 for the resale of Inducement Warrant shares by April 25, 2024.
- Debt Covenant Waivers:
- Available Cash Test: Waived until September 30, 2024.
- Amortization Payments: The right to receive amortization amounts for the next four consecutive dates is waived; these amounts are now due on the Maturity Date.
- Conversion Restrictions: For 60 days following the waiver, if the 3-day average closing price is below $0.25, conversion of Notes to Common Stock is prohibited. If the price is $0.25 or greater, conversion limitations are removed.
Outlook, Risks, and Contingencies
Stockholder Approval Requirement: The issuance of Inducement Warrants is contingent upon stockholder approval. The Company must hold a meeting within 90 days of the Final Closing Date. If approval is not obtained initially, the Company must call a meeting every 90 days thereafter until approval is secured or the warrants are no longer outstanding.
Regulatory Compliance: The issuance of Inducement Warrants is being made pursuant to exemptions under Section 4(a)(2) and Rule 506(b) of Regulation D. The Company intends to register the resale of shares issuable upon exercise of these warrants.
Market Price Sensitivity: The ability of Note holders to convert debt into equity is directly tied to the Company's stock price relative to the $0.25 threshold for the next 60 days.
Investor Verification Checklist
- Verify the outcome of the stockholder meeting required to approve the Inducement Warrants.
- Monitor the Company's stock price relative to the $0.25 threshold to assess conversion restrictions on Senior Secured Convertible Notes.
- Confirm the filing of the Form S-3 registration statement for Inducement Warrant shares by April 25, 2024.
- Review the actual exercise rate of the Existing Warrants by the March 26, 2024 deadline to determine actual cash proceeds.
- Assess the impact of the deferred amortization payments on the Company's liquidity and debt maturity profile.